Syphilis Testing
Syphilis Testing

Syphilis Testing Comprehensive Study by Type (Treponemal tests, Non-treponemal tests), Syphilis types (Primary Syphilis, Secondary Syphilis, Others (Latent (hidden) stage, Tertiary (late) stage)), Gender (Male, Female), Transmission mode (Genitals, Rectum, Mouth), End User (Hospitals, Clinics) Players and Region - Global Market Outlook to 2026

Syphilis Testing Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 214 Pages 177 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Syphilis Testing Market?

Syphilis is a sexually transferred infection caused by the bacteria Treponema pallidum subspecies pallidum that can produce serious health difficulties if it is not treated. Syphilis is divided into stages primary, secondary, latent, and tertiary. There are different signs and symptoms associated with each stage. Further, the infection can affect the infants too by the transmission of the infection from the infected mother to the fetus. The rate of syphilis is high among the men who have sex with the men. The increasing number of Unprotected sex and sexual intercourse with multiple partners affected by syphilis infection is one of the major key driving factors of the growth of syphilis testing.

The market study is being classified by Type (Treponemal tests and Non-treponemal tests) and major geographies with country level break-up.

Abbott Laboratories (United States), Affymetrix (United States), Alere (United States), Becton Dickinson And Company (United States), BioMerieux(France), Beckman Coulter Life Sciences (United States), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), AccuBioTech Co., Ltd. (China) and bioLytical Laboratories (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Chembio Diagnostic Systems(United States) and DRG International (United States).

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Syphilis Testing market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Syphilis Testing market by Type, Application and Region.

On the basis of geography, the market of Syphilis Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing prevalence and incidence of syphilis
  • Growing research and development activities

Market Trend
  • The increased use of premarital screening for syphilis is one of the key syphilis testing market trends

Restraints
  • Lack of awareness regarding syphilis testing

Opportunities
  • Increase in the prevalence of syphilis

Challenges
  • Discrepancies associated with the syphilis test results


In February 2020 Houston Health Department launches new campaign emphasizing the importance of prenatal care, syphilis testing for expectant mothers. The new campaign, called “My Prenatal Promise,” targets women of childbearing age (16-44), and emphasizes the importance of prenatal care and getting tested three times for syphilis, as required by Texas state law.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Syphilis Testing Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Treponemal tests
  • Non-treponemal tests
By Syphilis types
  • Primary Syphilis
  • Secondary Syphilis
  • Others (Latent (hidden) stage, Tertiary (late) stage)

By Gender
  • Male
  • Female

By Transmission mode
  • Genitals
  • Rectum
  • Mouth

By End User
  • Hospitals
  • Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence and incidence of syphilis
      • 3.2.2. Growing research and development activities
    • 3.3. Market Challenges
      • 3.3.1. Discrepancies associated with the syphilis test results
    • 3.4. Market Trends
      • 3.4.1. The increased use of premarital screening for syphilis is one of the key syphilis testing market trends
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Syphilis Testing, by Type, Syphilis types, Gender, Transmission mode, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Syphilis Testing (Value)
      • 5.2.1. Global Syphilis Testing by: Type (Value)
        • 5.2.1.1. Treponemal tests
        • 5.2.1.2. Non-treponemal tests
      • 5.2.2. Global Syphilis Testing by: Syphilis types (Value)
        • 5.2.2.1. Primary Syphilis
        • 5.2.2.2. Secondary Syphilis
        • 5.2.2.3. Others (Latent (hidden) stage, Tertiary (late) stage)
      • 5.2.3. Global Syphilis Testing by: Gender (Value)
        • 5.2.3.1. Male
        • 5.2.3.2. Female
      • 5.2.4. Global Syphilis Testing by: Transmission mode (Value)
        • 5.2.4.1. Genitals
        • 5.2.4.2. Rectum
        • 5.2.4.3. Mouth
      • 5.2.5. Global Syphilis Testing by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Clinics
      • 5.2.6. Global Syphilis Testing Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Syphilis Testing (Volume)
      • 5.3.1. Global Syphilis Testing by: Type (Volume)
        • 5.3.1.1. Treponemal tests
        • 5.3.1.2. Non-treponemal tests
      • 5.3.2. Global Syphilis Testing by: Syphilis types (Volume)
        • 5.3.2.1. Primary Syphilis
        • 5.3.2.2. Secondary Syphilis
        • 5.3.2.3. Others (Latent (hidden) stage, Tertiary (late) stage)
      • 5.3.3. Global Syphilis Testing by: Gender (Volume)
        • 5.3.3.1. Male
        • 5.3.3.2. Female
      • 5.3.4. Global Syphilis Testing by: Transmission mode (Volume)
        • 5.3.4.1. Genitals
        • 5.3.4.2. Rectum
        • 5.3.4.3. Mouth
      • 5.3.5. Global Syphilis Testing by: End User (Volume)
        • 5.3.5.1. Hospitals
        • 5.3.5.2. Clinics
      • 5.3.6. Global Syphilis Testing Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Syphilis Testing (Price)
      • 5.4.1. Global Syphilis Testing by: Type (Price)
  • 6. Syphilis Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Affymetrix (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alere (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton Dickinson And Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioMerieux(France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Beckman Coulter Life Sciences (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Roche Diagnostics (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Siemens Healthcare (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. AccuBioTech Co., Ltd. (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. BioLytical Laboratories (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Syphilis Testing Sale, by Type, Syphilis types, Gender, Transmission mode, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Syphilis Testing (Value)
      • 7.2.1. Global Syphilis Testing by: Type (Value)
        • 7.2.1.1. Treponemal tests
        • 7.2.1.2. Non-treponemal tests
      • 7.2.2. Global Syphilis Testing by: Syphilis types (Value)
        • 7.2.2.1. Primary Syphilis
        • 7.2.2.2. Secondary Syphilis
        • 7.2.2.3. Others (Latent (hidden) stage, Tertiary (late) stage)
      • 7.2.3. Global Syphilis Testing by: Gender (Value)
        • 7.2.3.1. Male
        • 7.2.3.2. Female
      • 7.2.4. Global Syphilis Testing by: Transmission mode (Value)
        • 7.2.4.1. Genitals
        • 7.2.4.2. Rectum
        • 7.2.4.3. Mouth
      • 7.2.5. Global Syphilis Testing by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Clinics
      • 7.2.6. Global Syphilis Testing Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Syphilis Testing (Volume)
      • 7.3.1. Global Syphilis Testing by: Type (Volume)
        • 7.3.1.1. Treponemal tests
        • 7.3.1.2. Non-treponemal tests
      • 7.3.2. Global Syphilis Testing by: Syphilis types (Volume)
        • 7.3.2.1. Primary Syphilis
        • 7.3.2.2. Secondary Syphilis
        • 7.3.2.3. Others (Latent (hidden) stage, Tertiary (late) stage)
      • 7.3.3. Global Syphilis Testing by: Gender (Volume)
        • 7.3.3.1. Male
        • 7.3.3.2. Female
      • 7.3.4. Global Syphilis Testing by: Transmission mode (Volume)
        • 7.3.4.1. Genitals
        • 7.3.4.2. Rectum
        • 7.3.4.3. Mouth
      • 7.3.5. Global Syphilis Testing by: End User (Volume)
        • 7.3.5.1. Hospitals
        • 7.3.5.2. Clinics
      • 7.3.6. Global Syphilis Testing Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Syphilis Testing (Price)
      • 7.4.1. Global Syphilis Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Syphilis Testing: by Type(USD Million)
  • Table 2. Syphilis Testing Treponemal tests , by Region USD Million (2015-2020)
  • Table 3. Syphilis Testing Non-treponemal tests , by Region USD Million (2015-2020)
  • Table 4. Syphilis Testing: by Syphilis types(USD Million)
  • Table 5. Syphilis Testing Primary Syphilis , by Region USD Million (2015-2020)
  • Table 6. Syphilis Testing Secondary Syphilis , by Region USD Million (2015-2020)
  • Table 7. Syphilis Testing Others (Latent (hidden) stage, Tertiary (late) stage) , by Region USD Million (2015-2020)
  • Table 8. Syphilis Testing: by Gender(USD Million)
  • Table 9. Syphilis Testing Male , by Region USD Million (2015-2020)
  • Table 10. Syphilis Testing Female , by Region USD Million (2015-2020)
  • Table 11. Syphilis Testing: by Transmission mode(USD Million)
  • Table 12. Syphilis Testing Genitals , by Region USD Million (2015-2020)
  • Table 13. Syphilis Testing Rectum , by Region USD Million (2015-2020)
  • Table 14. Syphilis Testing Mouth , by Region USD Million (2015-2020)
  • Table 15. Syphilis Testing: by End User(USD Million)
  • Table 16. Syphilis Testing Hospitals , by Region USD Million (2015-2020)
  • Table 17. Syphilis Testing Clinics , by Region USD Million (2015-2020)
  • Table 18. South America Syphilis Testing, by Country USD Million (2015-2020)
  • Table 19. South America Syphilis Testing, by Type USD Million (2015-2020)
  • Table 20. South America Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 21. South America Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 22. South America Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 23. South America Syphilis Testing, by End User USD Million (2015-2020)
  • Table 24. Brazil Syphilis Testing, by Type USD Million (2015-2020)
  • Table 25. Brazil Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 26. Brazil Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 27. Brazil Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 28. Brazil Syphilis Testing, by End User USD Million (2015-2020)
  • Table 29. Argentina Syphilis Testing, by Type USD Million (2015-2020)
  • Table 30. Argentina Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 31. Argentina Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 32. Argentina Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 33. Argentina Syphilis Testing, by End User USD Million (2015-2020)
  • Table 34. Rest of South America Syphilis Testing, by Type USD Million (2015-2020)
  • Table 35. Rest of South America Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 36. Rest of South America Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 37. Rest of South America Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 38. Rest of South America Syphilis Testing, by End User USD Million (2015-2020)
  • Table 39. Asia Pacific Syphilis Testing, by Country USD Million (2015-2020)
  • Table 40. Asia Pacific Syphilis Testing, by Type USD Million (2015-2020)
  • Table 41. Asia Pacific Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 42. Asia Pacific Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 43. Asia Pacific Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 44. Asia Pacific Syphilis Testing, by End User USD Million (2015-2020)
  • Table 45. China Syphilis Testing, by Type USD Million (2015-2020)
  • Table 46. China Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 47. China Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 48. China Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 49. China Syphilis Testing, by End User USD Million (2015-2020)
  • Table 50. Japan Syphilis Testing, by Type USD Million (2015-2020)
  • Table 51. Japan Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 52. Japan Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 53. Japan Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 54. Japan Syphilis Testing, by End User USD Million (2015-2020)
  • Table 55. India Syphilis Testing, by Type USD Million (2015-2020)
  • Table 56. India Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 57. India Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 58. India Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 59. India Syphilis Testing, by End User USD Million (2015-2020)
  • Table 60. South Korea Syphilis Testing, by Type USD Million (2015-2020)
  • Table 61. South Korea Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 62. South Korea Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 63. South Korea Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 64. South Korea Syphilis Testing, by End User USD Million (2015-2020)
  • Table 65. Taiwan Syphilis Testing, by Type USD Million (2015-2020)
  • Table 66. Taiwan Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 67. Taiwan Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 68. Taiwan Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 69. Taiwan Syphilis Testing, by End User USD Million (2015-2020)
  • Table 70. Australia Syphilis Testing, by Type USD Million (2015-2020)
  • Table 71. Australia Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 72. Australia Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 73. Australia Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 74. Australia Syphilis Testing, by End User USD Million (2015-2020)
  • Table 75. Rest of Asia-Pacific Syphilis Testing, by Type USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 77. Rest of Asia-Pacific Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 79. Rest of Asia-Pacific Syphilis Testing, by End User USD Million (2015-2020)
  • Table 80. Europe Syphilis Testing, by Country USD Million (2015-2020)
  • Table 81. Europe Syphilis Testing, by Type USD Million (2015-2020)
  • Table 82. Europe Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 83. Europe Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 84. Europe Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 85. Europe Syphilis Testing, by End User USD Million (2015-2020)
  • Table 86. Germany Syphilis Testing, by Type USD Million (2015-2020)
  • Table 87. Germany Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 88. Germany Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 89. Germany Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 90. Germany Syphilis Testing, by End User USD Million (2015-2020)
  • Table 91. France Syphilis Testing, by Type USD Million (2015-2020)
  • Table 92. France Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 93. France Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 94. France Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 95. France Syphilis Testing, by End User USD Million (2015-2020)
  • Table 96. Italy Syphilis Testing, by Type USD Million (2015-2020)
  • Table 97. Italy Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 98. Italy Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 99. Italy Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 100. Italy Syphilis Testing, by End User USD Million (2015-2020)
  • Table 101. United Kingdom Syphilis Testing, by Type USD Million (2015-2020)
  • Table 102. United Kingdom Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 103. United Kingdom Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 104. United Kingdom Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 105. United Kingdom Syphilis Testing, by End User USD Million (2015-2020)
  • Table 106. Netherlands Syphilis Testing, by Type USD Million (2015-2020)
  • Table 107. Netherlands Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 108. Netherlands Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 109. Netherlands Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 110. Netherlands Syphilis Testing, by End User USD Million (2015-2020)
  • Table 111. Rest of Europe Syphilis Testing, by Type USD Million (2015-2020)
  • Table 112. Rest of Europe Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 113. Rest of Europe Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 114. Rest of Europe Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 115. Rest of Europe Syphilis Testing, by End User USD Million (2015-2020)
  • Table 116. MEA Syphilis Testing, by Country USD Million (2015-2020)
  • Table 117. MEA Syphilis Testing, by Type USD Million (2015-2020)
  • Table 118. MEA Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 119. MEA Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 120. MEA Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 121. MEA Syphilis Testing, by End User USD Million (2015-2020)
  • Table 122. Middle East Syphilis Testing, by Type USD Million (2015-2020)
  • Table 123. Middle East Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 124. Middle East Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 125. Middle East Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 126. Middle East Syphilis Testing, by End User USD Million (2015-2020)
  • Table 127. Africa Syphilis Testing, by Type USD Million (2015-2020)
  • Table 128. Africa Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 129. Africa Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 130. Africa Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 131. Africa Syphilis Testing, by End User USD Million (2015-2020)
  • Table 132. North America Syphilis Testing, by Country USD Million (2015-2020)
  • Table 133. North America Syphilis Testing, by Type USD Million (2015-2020)
  • Table 134. North America Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 135. North America Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 136. North America Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 137. North America Syphilis Testing, by End User USD Million (2015-2020)
  • Table 138. United States Syphilis Testing, by Type USD Million (2015-2020)
  • Table 139. United States Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 140. United States Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 141. United States Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 142. United States Syphilis Testing, by End User USD Million (2015-2020)
  • Table 143. Canada Syphilis Testing, by Type USD Million (2015-2020)
  • Table 144. Canada Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 145. Canada Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 146. Canada Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 147. Canada Syphilis Testing, by End User USD Million (2015-2020)
  • Table 148. Mexico Syphilis Testing, by Type USD Million (2015-2020)
  • Table 149. Mexico Syphilis Testing, by Syphilis types USD Million (2015-2020)
  • Table 150. Mexico Syphilis Testing, by Gender USD Million (2015-2020)
  • Table 151. Mexico Syphilis Testing, by Transmission mode USD Million (2015-2020)
  • Table 152. Mexico Syphilis Testing, by End User USD Million (2015-2020)
  • Table 153. Syphilis Testing Sales: by Type(K Units)
  • Table 154. Syphilis Testing Sales Treponemal tests , by Region K Units (2015-2020)
  • Table 155. Syphilis Testing Sales Non-treponemal tests , by Region K Units (2015-2020)
  • Table 156. Syphilis Testing Sales: by Syphilis types(K Units)
  • Table 157. Syphilis Testing Sales Primary Syphilis , by Region K Units (2015-2020)
  • Table 158. Syphilis Testing Sales Secondary Syphilis , by Region K Units (2015-2020)
  • Table 159. Syphilis Testing Sales Others (Latent (hidden) stage, Tertiary (late) stage) , by Region K Units (2015-2020)
  • Table 160. Syphilis Testing Sales: by Gender(K Units)
  • Table 161. Syphilis Testing Sales Male , by Region K Units (2015-2020)
  • Table 162. Syphilis Testing Sales Female , by Region K Units (2015-2020)
  • Table 163. Syphilis Testing Sales: by Transmission mode(K Units)
  • Table 164. Syphilis Testing Sales Genitals , by Region K Units (2015-2020)
  • Table 165. Syphilis Testing Sales Rectum , by Region K Units (2015-2020)
  • Table 166. Syphilis Testing Sales Mouth , by Region K Units (2015-2020)
  • Table 167. Syphilis Testing Sales: by End User(K Units)
  • Table 168. Syphilis Testing Sales Hospitals , by Region K Units (2015-2020)
  • Table 169. Syphilis Testing Sales Clinics , by Region K Units (2015-2020)
  • Table 170. South America Syphilis Testing Sales, by Country K Units (2015-2020)
  • Table 171. South America Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 172. South America Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 173. South America Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 174. South America Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 175. South America Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 176. Brazil Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 177. Brazil Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 178. Brazil Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 179. Brazil Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 180. Brazil Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 181. Argentina Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 182. Argentina Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 183. Argentina Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 184. Argentina Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 185. Argentina Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 186. Rest of South America Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 187. Rest of South America Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 188. Rest of South America Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 189. Rest of South America Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 190. Rest of South America Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 191. Asia Pacific Syphilis Testing Sales, by Country K Units (2015-2020)
  • Table 192. Asia Pacific Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 193. Asia Pacific Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 194. Asia Pacific Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 195. Asia Pacific Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 196. Asia Pacific Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 197. China Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 198. China Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 199. China Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 200. China Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 201. China Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 202. Japan Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 203. Japan Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 204. Japan Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 205. Japan Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 206. Japan Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 207. India Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 208. India Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 209. India Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 210. India Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 211. India Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 212. South Korea Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 213. South Korea Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 214. South Korea Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 215. South Korea Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 216. South Korea Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 217. Taiwan Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 218. Taiwan Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 219. Taiwan Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 220. Taiwan Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 221. Taiwan Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 222. Australia Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 223. Australia Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 224. Australia Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 225. Australia Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 226. Australia Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 227. Rest of Asia-Pacific Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 228. Rest of Asia-Pacific Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 229. Rest of Asia-Pacific Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 230. Rest of Asia-Pacific Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 231. Rest of Asia-Pacific Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 232. Europe Syphilis Testing Sales, by Country K Units (2015-2020)
  • Table 233. Europe Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 234. Europe Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 235. Europe Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 236. Europe Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 237. Europe Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 238. Germany Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 239. Germany Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 240. Germany Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 241. Germany Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 242. Germany Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 243. France Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 244. France Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 245. France Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 246. France Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 247. France Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 248. Italy Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 249. Italy Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 250. Italy Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 251. Italy Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 252. Italy Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 253. United Kingdom Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 254. United Kingdom Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 255. United Kingdom Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 256. United Kingdom Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 257. United Kingdom Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 258. Netherlands Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 259. Netherlands Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 260. Netherlands Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 261. Netherlands Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 262. Netherlands Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 263. Rest of Europe Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 264. Rest of Europe Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 265. Rest of Europe Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 266. Rest of Europe Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 267. Rest of Europe Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 268. MEA Syphilis Testing Sales, by Country K Units (2015-2020)
  • Table 269. MEA Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 270. MEA Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 271. MEA Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 272. MEA Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 273. MEA Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 274. Middle East Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 275. Middle East Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 276. Middle East Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 277. Middle East Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 278. Middle East Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 279. Africa Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 280. Africa Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 281. Africa Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 282. Africa Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 283. Africa Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 284. North America Syphilis Testing Sales, by Country K Units (2015-2020)
  • Table 285. North America Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 286. North America Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 287. North America Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 288. North America Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 289. North America Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 290. United States Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 291. United States Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 292. United States Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 293. United States Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 294. United States Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 295. Canada Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 296. Canada Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 297. Canada Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 298. Canada Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 299. Canada Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 300. Mexico Syphilis Testing Sales, by Type K Units (2015-2020)
  • Table 301. Mexico Syphilis Testing Sales, by Syphilis types K Units (2015-2020)
  • Table 302. Mexico Syphilis Testing Sales, by Gender K Units (2015-2020)
  • Table 303. Mexico Syphilis Testing Sales, by Transmission mode K Units (2015-2020)
  • Table 304. Mexico Syphilis Testing Sales, by End User K Units (2015-2020)
  • Table 305. Syphilis Testing: by Type(USD/Units)
  • Table 306. Company Basic Information, Sales Area and Its Competitors
  • Table 307. Company Basic Information, Sales Area and Its Competitors
  • Table 308. Company Basic Information, Sales Area and Its Competitors
  • Table 309. Company Basic Information, Sales Area and Its Competitors
  • Table 310. Company Basic Information, Sales Area and Its Competitors
  • Table 311. Company Basic Information, Sales Area and Its Competitors
  • Table 312. Company Basic Information, Sales Area and Its Competitors
  • Table 313. Company Basic Information, Sales Area and Its Competitors
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Syphilis Testing: by Type(USD Million)
  • Table 317. Syphilis Testing Treponemal tests , by Region USD Million (2021-2026)
  • Table 318. Syphilis Testing Non-treponemal tests , by Region USD Million (2021-2026)
  • Table 319. Syphilis Testing: by Syphilis types(USD Million)
  • Table 320. Syphilis Testing Primary Syphilis , by Region USD Million (2021-2026)
  • Table 321. Syphilis Testing Secondary Syphilis , by Region USD Million (2021-2026)
  • Table 322. Syphilis Testing Others (Latent (hidden) stage, Tertiary (late) stage) , by Region USD Million (2021-2026)
  • Table 323. Syphilis Testing: by Gender(USD Million)
  • Table 324. Syphilis Testing Male , by Region USD Million (2021-2026)
  • Table 325. Syphilis Testing Female , by Region USD Million (2021-2026)
  • Table 326. Syphilis Testing: by Transmission mode(USD Million)
  • Table 327. Syphilis Testing Genitals , by Region USD Million (2021-2026)
  • Table 328. Syphilis Testing Rectum , by Region USD Million (2021-2026)
  • Table 329. Syphilis Testing Mouth , by Region USD Million (2021-2026)
  • Table 330. Syphilis Testing: by End User(USD Million)
  • Table 331. Syphilis Testing Hospitals , by Region USD Million (2021-2026)
  • Table 332. Syphilis Testing Clinics , by Region USD Million (2021-2026)
  • Table 333. South America Syphilis Testing, by Country USD Million (2021-2026)
  • Table 334. South America Syphilis Testing, by Type USD Million (2021-2026)
  • Table 335. South America Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 336. South America Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 337. South America Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 338. South America Syphilis Testing, by End User USD Million (2021-2026)
  • Table 339. Brazil Syphilis Testing, by Type USD Million (2021-2026)
  • Table 340. Brazil Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 341. Brazil Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 342. Brazil Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 343. Brazil Syphilis Testing, by End User USD Million (2021-2026)
  • Table 344. Argentina Syphilis Testing, by Type USD Million (2021-2026)
  • Table 345. Argentina Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 346. Argentina Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 347. Argentina Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 348. Argentina Syphilis Testing, by End User USD Million (2021-2026)
  • Table 349. Rest of South America Syphilis Testing, by Type USD Million (2021-2026)
  • Table 350. Rest of South America Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 351. Rest of South America Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 352. Rest of South America Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 353. Rest of South America Syphilis Testing, by End User USD Million (2021-2026)
  • Table 354. Asia Pacific Syphilis Testing, by Country USD Million (2021-2026)
  • Table 355. Asia Pacific Syphilis Testing, by Type USD Million (2021-2026)
  • Table 356. Asia Pacific Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 357. Asia Pacific Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 358. Asia Pacific Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 359. Asia Pacific Syphilis Testing, by End User USD Million (2021-2026)
  • Table 360. China Syphilis Testing, by Type USD Million (2021-2026)
  • Table 361. China Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 362. China Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 363. China Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 364. China Syphilis Testing, by End User USD Million (2021-2026)
  • Table 365. Japan Syphilis Testing, by Type USD Million (2021-2026)
  • Table 366. Japan Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 367. Japan Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 368. Japan Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 369. Japan Syphilis Testing, by End User USD Million (2021-2026)
  • Table 370. India Syphilis Testing, by Type USD Million (2021-2026)
  • Table 371. India Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 372. India Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 373. India Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 374. India Syphilis Testing, by End User USD Million (2021-2026)
  • Table 375. South Korea Syphilis Testing, by Type USD Million (2021-2026)
  • Table 376. South Korea Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 377. South Korea Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 378. South Korea Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 379. South Korea Syphilis Testing, by End User USD Million (2021-2026)
  • Table 380. Taiwan Syphilis Testing, by Type USD Million (2021-2026)
  • Table 381. Taiwan Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 382. Taiwan Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 383. Taiwan Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 384. Taiwan Syphilis Testing, by End User USD Million (2021-2026)
  • Table 385. Australia Syphilis Testing, by Type USD Million (2021-2026)
  • Table 386. Australia Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 387. Australia Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 388. Australia Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 389. Australia Syphilis Testing, by End User USD Million (2021-2026)
  • Table 390. Rest of Asia-Pacific Syphilis Testing, by Type USD Million (2021-2026)
  • Table 391. Rest of Asia-Pacific Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 392. Rest of Asia-Pacific Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 393. Rest of Asia-Pacific Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 394. Rest of Asia-Pacific Syphilis Testing, by End User USD Million (2021-2026)
  • Table 395. Europe Syphilis Testing, by Country USD Million (2021-2026)
  • Table 396. Europe Syphilis Testing, by Type USD Million (2021-2026)
  • Table 397. Europe Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 398. Europe Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 399. Europe Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 400. Europe Syphilis Testing, by End User USD Million (2021-2026)
  • Table 401. Germany Syphilis Testing, by Type USD Million (2021-2026)
  • Table 402. Germany Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 403. Germany Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 404. Germany Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 405. Germany Syphilis Testing, by End User USD Million (2021-2026)
  • Table 406. France Syphilis Testing, by Type USD Million (2021-2026)
  • Table 407. France Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 408. France Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 409. France Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 410. France Syphilis Testing, by End User USD Million (2021-2026)
  • Table 411. Italy Syphilis Testing, by Type USD Million (2021-2026)
  • Table 412. Italy Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 413. Italy Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 414. Italy Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 415. Italy Syphilis Testing, by End User USD Million (2021-2026)
  • Table 416. United Kingdom Syphilis Testing, by Type USD Million (2021-2026)
  • Table 417. United Kingdom Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 418. United Kingdom Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 419. United Kingdom Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 420. United Kingdom Syphilis Testing, by End User USD Million (2021-2026)
  • Table 421. Netherlands Syphilis Testing, by Type USD Million (2021-2026)
  • Table 422. Netherlands Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 423. Netherlands Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 424. Netherlands Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 425. Netherlands Syphilis Testing, by End User USD Million (2021-2026)
  • Table 426. Rest of Europe Syphilis Testing, by Type USD Million (2021-2026)
  • Table 427. Rest of Europe Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 428. Rest of Europe Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 429. Rest of Europe Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 430. Rest of Europe Syphilis Testing, by End User USD Million (2021-2026)
  • Table 431. MEA Syphilis Testing, by Country USD Million (2021-2026)
  • Table 432. MEA Syphilis Testing, by Type USD Million (2021-2026)
  • Table 433. MEA Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 434. MEA Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 435. MEA Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 436. MEA Syphilis Testing, by End User USD Million (2021-2026)
  • Table 437. Middle East Syphilis Testing, by Type USD Million (2021-2026)
  • Table 438. Middle East Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 439. Middle East Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 440. Middle East Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 441. Middle East Syphilis Testing, by End User USD Million (2021-2026)
  • Table 442. Africa Syphilis Testing, by Type USD Million (2021-2026)
  • Table 443. Africa Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 444. Africa Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 445. Africa Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 446. Africa Syphilis Testing, by End User USD Million (2021-2026)
  • Table 447. North America Syphilis Testing, by Country USD Million (2021-2026)
  • Table 448. North America Syphilis Testing, by Type USD Million (2021-2026)
  • Table 449. North America Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 450. North America Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 451. North America Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 452. North America Syphilis Testing, by End User USD Million (2021-2026)
  • Table 453. United States Syphilis Testing, by Type USD Million (2021-2026)
  • Table 454. United States Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 455. United States Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 456. United States Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 457. United States Syphilis Testing, by End User USD Million (2021-2026)
  • Table 458. Canada Syphilis Testing, by Type USD Million (2021-2026)
  • Table 459. Canada Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 460. Canada Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 461. Canada Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 462. Canada Syphilis Testing, by End User USD Million (2021-2026)
  • Table 463. Mexico Syphilis Testing, by Type USD Million (2021-2026)
  • Table 464. Mexico Syphilis Testing, by Syphilis types USD Million (2021-2026)
  • Table 465. Mexico Syphilis Testing, by Gender USD Million (2021-2026)
  • Table 466. Mexico Syphilis Testing, by Transmission mode USD Million (2021-2026)
  • Table 467. Mexico Syphilis Testing, by End User USD Million (2021-2026)
  • Table 468. Syphilis Testing Sales: by Type(K Units)
  • Table 469. Syphilis Testing Sales Treponemal tests , by Region K Units (2021-2026)
  • Table 470. Syphilis Testing Sales Non-treponemal tests , by Region K Units (2021-2026)
  • Table 471. Syphilis Testing Sales: by Syphilis types(K Units)
  • Table 472. Syphilis Testing Sales Primary Syphilis , by Region K Units (2021-2026)
  • Table 473. Syphilis Testing Sales Secondary Syphilis , by Region K Units (2021-2026)
  • Table 474. Syphilis Testing Sales Others (Latent (hidden) stage, Tertiary (late) stage) , by Region K Units (2021-2026)
  • Table 475. Syphilis Testing Sales: by Gender(K Units)
  • Table 476. Syphilis Testing Sales Male , by Region K Units (2021-2026)
  • Table 477. Syphilis Testing Sales Female , by Region K Units (2021-2026)
  • Table 478. Syphilis Testing Sales: by Transmission mode(K Units)
  • Table 479. Syphilis Testing Sales Genitals , by Region K Units (2021-2026)
  • Table 480. Syphilis Testing Sales Rectum , by Region K Units (2021-2026)
  • Table 481. Syphilis Testing Sales Mouth , by Region K Units (2021-2026)
  • Table 482. Syphilis Testing Sales: by End User(K Units)
  • Table 483. Syphilis Testing Sales Hospitals , by Region K Units (2021-2026)
  • Table 484. Syphilis Testing Sales Clinics , by Region K Units (2021-2026)
  • Table 485. South America Syphilis Testing Sales, by Country K Units (2021-2026)
  • Table 486. South America Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 487. South America Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 488. South America Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 489. South America Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 490. South America Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 491. Brazil Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 492. Brazil Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 493. Brazil Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 494. Brazil Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 495. Brazil Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 496. Argentina Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 497. Argentina Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 498. Argentina Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 499. Argentina Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 500. Argentina Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 501. Rest of South America Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 502. Rest of South America Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 503. Rest of South America Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 504. Rest of South America Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 505. Rest of South America Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 506. Asia Pacific Syphilis Testing Sales, by Country K Units (2021-2026)
  • Table 507. Asia Pacific Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 508. Asia Pacific Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 509. Asia Pacific Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 510. Asia Pacific Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 511. Asia Pacific Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 512. China Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 513. China Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 514. China Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 515. China Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 516. China Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 517. Japan Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 518. Japan Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 519. Japan Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 520. Japan Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 521. Japan Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 522. India Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 523. India Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 524. India Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 525. India Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 526. India Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 527. South Korea Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 528. South Korea Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 529. South Korea Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 530. South Korea Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 531. South Korea Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 532. Taiwan Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 533. Taiwan Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 534. Taiwan Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 535. Taiwan Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 536. Taiwan Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 537. Australia Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 538. Australia Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 539. Australia Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 540. Australia Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 541. Australia Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 542. Rest of Asia-Pacific Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 543. Rest of Asia-Pacific Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 544. Rest of Asia-Pacific Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 545. Rest of Asia-Pacific Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 546. Rest of Asia-Pacific Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 547. Europe Syphilis Testing Sales, by Country K Units (2021-2026)
  • Table 548. Europe Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 549. Europe Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 550. Europe Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 551. Europe Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 552. Europe Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 553. Germany Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 554. Germany Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 555. Germany Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 556. Germany Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 557. Germany Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 558. France Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 559. France Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 560. France Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 561. France Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 562. France Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 563. Italy Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 564. Italy Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 565. Italy Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 566. Italy Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 567. Italy Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 568. United Kingdom Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 569. United Kingdom Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 570. United Kingdom Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 571. United Kingdom Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 572. United Kingdom Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 573. Netherlands Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 574. Netherlands Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 575. Netherlands Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 576. Netherlands Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 577. Netherlands Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 578. Rest of Europe Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 579. Rest of Europe Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 580. Rest of Europe Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 581. Rest of Europe Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 582. Rest of Europe Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 583. MEA Syphilis Testing Sales, by Country K Units (2021-2026)
  • Table 584. MEA Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 585. MEA Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 586. MEA Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 587. MEA Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 588. MEA Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 589. Middle East Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 590. Middle East Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 591. Middle East Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 592. Middle East Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 593. Middle East Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 594. Africa Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 595. Africa Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 596. Africa Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 597. Africa Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 598. Africa Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 599. North America Syphilis Testing Sales, by Country K Units (2021-2026)
  • Table 600. North America Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 601. North America Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 602. North America Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 603. North America Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 604. North America Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 605. United States Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 606. United States Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 607. United States Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 608. United States Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 609. United States Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 610. Canada Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 611. Canada Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 612. Canada Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 613. Canada Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 614. Canada Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 615. Mexico Syphilis Testing Sales, by Type K Units (2021-2026)
  • Table 616. Mexico Syphilis Testing Sales, by Syphilis types K Units (2021-2026)
  • Table 617. Mexico Syphilis Testing Sales, by Gender K Units (2021-2026)
  • Table 618. Mexico Syphilis Testing Sales, by Transmission mode K Units (2021-2026)
  • Table 619. Mexico Syphilis Testing Sales, by End User K Units (2021-2026)
  • Table 620. Syphilis Testing: by Type(USD/Units)
  • Table 621. Research Programs/Design for This Report
  • Table 622. Key Data Information from Secondary Sources
  • Table 623. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Syphilis Testing: by Type USD Million (2015-2020)
  • Figure 5. Global Syphilis Testing: by Syphilis types USD Million (2015-2020)
  • Figure 6. Global Syphilis Testing: by Gender USD Million (2015-2020)
  • Figure 7. Global Syphilis Testing: by Transmission mode USD Million (2015-2020)
  • Figure 8. Global Syphilis Testing: by End User USD Million (2015-2020)
  • Figure 9. South America Syphilis Testing Share (%), by Country
  • Figure 10. Asia Pacific Syphilis Testing Share (%), by Country
  • Figure 11. Europe Syphilis Testing Share (%), by Country
  • Figure 12. MEA Syphilis Testing Share (%), by Country
  • Figure 13. North America Syphilis Testing Share (%), by Country
  • Figure 14. Global Syphilis Testing: by Type K Units (2015-2020)
  • Figure 15. Global Syphilis Testing: by Syphilis types K Units (2015-2020)
  • Figure 16. Global Syphilis Testing: by Gender K Units (2015-2020)
  • Figure 17. Global Syphilis Testing: by Transmission mode K Units (2015-2020)
  • Figure 18. Global Syphilis Testing: by End User K Units (2015-2020)
  • Figure 19. South America Syphilis Testing Share (%), by Country
  • Figure 20. Asia Pacific Syphilis Testing Share (%), by Country
  • Figure 21. Europe Syphilis Testing Share (%), by Country
  • Figure 22. MEA Syphilis Testing Share (%), by Country
  • Figure 23. North America Syphilis Testing Share (%), by Country
  • Figure 24. Global Syphilis Testing: by Type USD/Units (2015-2020)
  • Figure 25. Global Syphilis Testing share by Players 2020 (%)
  • Figure 26. Global Syphilis Testing share by Players (Top 3) 2020(%)
  • Figure 27. Global Syphilis Testing share by Players (Top 5) 2020(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 31. Affymetrix (United States) Revenue, Net Income and Gross profit
  • Figure 32. Affymetrix (United States) Revenue: by Geography 2020
  • Figure 33. Alere (United States) Revenue, Net Income and Gross profit
  • Figure 34. Alere (United States) Revenue: by Geography 2020
  • Figure 35. Becton Dickinson And Company (United States) Revenue, Net Income and Gross profit
  • Figure 36. Becton Dickinson And Company (United States) Revenue: by Geography 2020
  • Figure 37. BioMerieux(France) Revenue, Net Income and Gross profit
  • Figure 38. BioMerieux(France) Revenue: by Geography 2020
  • Figure 39. Beckman Coulter Life Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 40. Beckman Coulter Life Sciences (United States) Revenue: by Geography 2020
  • Figure 41. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Roche Diagnostics (Switzerland) Revenue: by Geography 2020
  • Figure 43. Siemens Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Siemens Healthcare (Germany) Revenue: by Geography 2020
  • Figure 45. AccuBioTech Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 46. AccuBioTech Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 47. BioLytical Laboratories (Canada) Revenue, Net Income and Gross profit
  • Figure 48. BioLytical Laboratories (Canada) Revenue: by Geography 2020
  • Figure 49. Global Syphilis Testing: by Type USD Million (2021-2026)
  • Figure 50. Global Syphilis Testing: by Syphilis types USD Million (2021-2026)
  • Figure 51. Global Syphilis Testing: by Gender USD Million (2021-2026)
  • Figure 52. Global Syphilis Testing: by Transmission mode USD Million (2021-2026)
  • Figure 53. Global Syphilis Testing: by End User USD Million (2021-2026)
  • Figure 54. South America Syphilis Testing Share (%), by Country
  • Figure 55. Asia Pacific Syphilis Testing Share (%), by Country
  • Figure 56. Europe Syphilis Testing Share (%), by Country
  • Figure 57. MEA Syphilis Testing Share (%), by Country
  • Figure 58. North America Syphilis Testing Share (%), by Country
  • Figure 59. Global Syphilis Testing: by Type K Units (2021-2026)
  • Figure 60. Global Syphilis Testing: by Syphilis types K Units (2021-2026)
  • Figure 61. Global Syphilis Testing: by Gender K Units (2021-2026)
  • Figure 62. Global Syphilis Testing: by Transmission mode K Units (2021-2026)
  • Figure 63. Global Syphilis Testing: by End User K Units (2021-2026)
  • Figure 64. South America Syphilis Testing Share (%), by Country
  • Figure 65. Asia Pacific Syphilis Testing Share (%), by Country
  • Figure 66. Europe Syphilis Testing Share (%), by Country
  • Figure 67. MEA Syphilis Testing Share (%), by Country
  • Figure 68. North America Syphilis Testing Share (%), by Country
  • Figure 69. Global Syphilis Testing: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Affymetrix (United States)
  • Alere (United States)
  • Becton Dickinson And Company (United States)
  • BioMerieux(France)
  • Beckman Coulter Life Sciences (United States)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare (Germany)
  • AccuBioTech Co., Ltd. (China)
  • bioLytical Laboratories (Canada)
Additional players considered in the study are as follows:
Chembio Diagnostic Systems(United States) , DRG International (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation